HEADER VIRAL PROTEIN 22-MAY-20 6X45 TITLE SARS-COV2 SPIKE GLYCOPROTEIN N-TERMINAL HEPTAD REPEAT DOMAIN + SARS- TITLE 2 COV2(QEYKKEKE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SPIKE PROTEIN S2'; COMPND 3 CHAIN: E, D, F; COMPND 4 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN C- COMPND 5 TERMINAL HEPTAD REPEAT DOMAIN (QEYKKEKE); COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: THIS COMPOUND IS DERIVED FROM THE SARS-COV2 SPIKE COMPND 9 GLYCOPROTEIN C-TERMINAL HEPTAD REPEAT DOMAIN RESIDUES 1168-1203 WITH COMPND 10 SUBSTITUTIONS G1171Q, Q1180E, K1181Y, D1184K, R1185K, N1187E, N1192K, COMPND 11 N1194E. IT IS ACETYLATED AT THE N-TERMINUS AND AMIDATED AT THE C- COMPND 12 TERMINUS.; COMPND 13 MOL_ID: 2; COMPND 14 MOLECULE: SPIKE PROTEIN S2'; COMPND 15 CHAIN: C, B, A; COMPND 16 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN N- COMPND 17 TERMINAL HEPTAD REPEAT DOMAIN; COMPND 18 ENGINEERED: YES; COMPND 19 OTHER_DETAILS: THIS COMPOUND IS DERIVED FROM THE SARS-COV2 SPIKE COMPND 20 GLYCOPROTEIN N-TERMINAL HEPTAD REPEAT DOMAIN RESIDUES 912-966. IT IS COMPND 21 ACETYLATED AT THE N-TERMINUS AND AMIDATED AT THE C-TERMINUS. SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 4 2; SOURCE 5 ORGANISM_COMMON: 2019-NCOV; SOURCE 6 ORGANISM_TAXID: 2697049; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 10 2; SOURCE 11 ORGANISM_COMMON: 2019-NCOV; SOURCE 12 ORGANISM_TAXID: 2697049 KEYWDS CORONAVIRUS, COVID-19, SARS-COV-2, SPIKE, ANTIVIRAL, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.F.KREITLER,V.K.OUTLAW,S.H.GELLMAN REVDAT 3 16-OCT-24 6X45 1 REMARK REVDAT 2 18-OCT-23 6X45 1 REMARK REVDAT 1 24-NOV-21 6X45 0 JRNL AUTH V.K.OUTLAW,Z.YU,D.F.KREITLER,F.BOVIER,M.POROTTO,A.MOSCONA, JRNL AUTH 2 S.H.GELLMAN JRNL TITL ENGINEERED PEPTIDES POTENTLY BLOCK ENTRY OF SARS-COV-2 INTO JRNL TITL 2 HUMAN AIRWAY CELLS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 12313 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.246 REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1217 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.0400 - 4.5800 0.98 1314 138 0.2548 0.2935 REMARK 3 2 4.5700 - 3.6300 0.99 1251 137 0.2042 0.2414 REMARK 3 3 3.6300 - 3.1700 0.99 1235 142 0.2339 0.2574 REMARK 3 4 3.1700 - 2.8800 0.99 1232 138 0.2448 0.2800 REMARK 3 5 2.8800 - 2.6800 1.00 1208 133 0.2510 0.2779 REMARK 3 6 2.6800 - 2.5200 0.99 1236 132 0.2661 0.3055 REMARK 3 7 2.5200 - 2.3900 0.99 1205 135 0.2778 0.2860 REMARK 3 8 2.3900 - 2.2900 0.99 1207 129 0.3000 0.3594 REMARK 3 9 2.2900 - 2.2000 0.99 1208 133 0.3284 0.4037 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.327 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.892 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 88.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 1979 REMARK 3 ANGLE : 0.365 2667 REMARK 3 CHIRALITY : 0.034 335 REMARK 3 PLANARITY : 0.001 344 REMARK 3 DIHEDRAL : 19.217 738 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 14.4061 5.3348 37.9271 REMARK 3 T TENSOR REMARK 3 T11: 0.3605 T22: 0.3704 REMARK 3 T33: 0.4093 T12: 0.0215 REMARK 3 T13: -0.0023 T23: 0.0140 REMARK 3 L TENSOR REMARK 3 L11: 0.5900 L22: 1.4793 REMARK 3 L33: 2.1864 L12: -0.6349 REMARK 3 L13: 0.2611 L23: -0.5299 REMARK 3 S TENSOR REMARK 3 S11: 0.0668 S12: -0.1372 S13: 0.0342 REMARK 3 S21: 0.2424 S22: 0.0833 S23: 0.3346 REMARK 3 S31: -0.1681 S32: -0.1393 S33: 0.0298 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6X45 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-MAY-20. REMARK 100 THE DEPOSITION ID IS D_1000249414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-MAY-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS-II REMARK 200 BEAMLINE : 17-ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920087 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC 1.0.5, AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12351 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 80.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08800 REMARK 200 FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 1.56500 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6LXT REMARK 200 REMARK 200 REMARK: 3D BRICKS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEPTIDE SOLUTION: LYOPHILIZED TFA SALT REMARK 280 DISSOLVED IN 1% W/V BETA-D-OCTYLGLUCOSIDE; HRN (4 MG/ML), HRC- REMARK 280 QEYKKEKE (3 MG/ML) WELL SOLUTION: 0.1 M TRIS PH 7.8, 26% W/V REMARK 280 PEG3350, 0.3 M MGCL2 DROP: 1 UL PEPTIDE SOLUTION, 1 UL WELL REMARK 280 SOLUTION RESERVOIR: 150 UL IN VDXM PLATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.77150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.22900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.77150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.22900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 14540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12600 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -133.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, D, C, F, B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ACE E 1167 REMARK 465 GLU E 1202 REMARK 465 LEU E 1203 REMARK 465 NH2 E 1204 REMARK 465 ACE D 1167 REMARK 465 ACE C 911 REMARK 465 THR C 912 REMARK 465 GLN C 913 REMARK 465 LEU C 966 REMARK 465 NH2 C 967 REMARK 465 ACE F 1167 REMARK 465 GLU F 1202 REMARK 465 LEU F 1203 REMARK 465 NH2 F 1204 REMARK 465 ACE B 911 REMARK 465 THR B 912 REMARK 465 GLN B 913 REMARK 465 NH2 B 967 REMARK 465 ACE A 911 REMARK 465 THR A 912 REMARK 465 GLN A 913 REMARK 465 ASN A 914 REMARK 465 VAL A 915 REMARK 465 NH2 A 967 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP E1168 CG OD1 OD2 REMARK 470 SER E1170 OG REMARK 470 GLN E1201 CG CD OE1 NE2 REMARK 470 SER D1170 OG REMARK 470 ASN C 914 CG OD1 ND2 REMARK 470 GLN C 920 CG CD OE1 NE2 REMARK 470 VAL C 963 CG1 CG2 REMARK 470 ASP F1168 CG OD1 OD2 REMARK 470 SER F1170 OG REMARK 470 GLN F1171 CG CD OE1 NE2 REMARK 470 LEU F1200 CG CD1 CD2 REMARK 470 ASN B 914 CG OD1 ND2 REMARK 470 LEU B 916 CG CD1 CD2 REMARK 470 LEU A 916 CG CD1 CD2 REMARK 470 LEU A 966 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ASN B 914 H GLU B 918 1.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER E1170 -3.15 78.85 REMARK 500 REMARK 500 REMARK: NULL DBREF 6X45 E 1168 1203 UNP P0DTC2 SPIKE_SARS2 1168 1203 DBREF 6X45 D 1168 1203 UNP P0DTC2 SPIKE_SARS2 1168 1203 DBREF 6X45 C 912 966 UNP P0DTC2 SPIKE_SARS2 912 966 DBREF 6X45 F 1168 1203 UNP P0DTC2 SPIKE_SARS2 1168 1203 DBREF 6X45 B 912 966 UNP P0DTC2 SPIKE_SARS2 912 966 DBREF 6X45 A 912 966 UNP P0DTC2 SPIKE_SARS2 912 966 SEQADV 6X45 ACE E 1167 UNP P0DTC2 ACETYLATION SEQADV 6X45 GLN E 1171 UNP P0DTC2 GLY 1171 ENGINEERED MUTATION SEQADV 6X45 GLU E 1180 UNP P0DTC2 GLN 1180 ENGINEERED MUTATION SEQADV 6X45 TYR E 1181 UNP P0DTC2 LYS 1181 ENGINEERED MUTATION SEQADV 6X45 LYS E 1184 UNP P0DTC2 ASP 1184 ENGINEERED MUTATION SEQADV 6X45 LYS E 1185 UNP P0DTC2 ARG 1185 ENGINEERED MUTATION SEQADV 6X45 GLU E 1187 UNP P0DTC2 ASN 1187 ENGINEERED MUTATION SEQADV 6X45 LYS E 1192 UNP P0DTC2 ASN 1192 ENGINEERED MUTATION SEQADV 6X45 GLU E 1194 UNP P0DTC2 ASN 1194 ENGINEERED MUTATION SEQADV 6X45 NH2 E 1204 UNP P0DTC2 AMIDATION SEQADV 6X45 ACE D 1167 UNP P0DTC2 ACETYLATION SEQADV 6X45 GLN D 1171 UNP P0DTC2 GLY 1171 ENGINEERED MUTATION SEQADV 6X45 GLU D 1180 UNP P0DTC2 GLN 1180 ENGINEERED MUTATION SEQADV 6X45 TYR D 1181 UNP P0DTC2 LYS 1181 ENGINEERED MUTATION SEQADV 6X45 LYS D 1184 UNP P0DTC2 ASP 1184 ENGINEERED MUTATION SEQADV 6X45 LYS D 1185 UNP P0DTC2 ARG 1185 ENGINEERED MUTATION SEQADV 6X45 GLU D 1187 UNP P0DTC2 ASN 1187 ENGINEERED MUTATION SEQADV 6X45 LYS D 1192 UNP P0DTC2 ASN 1192 ENGINEERED MUTATION SEQADV 6X45 GLU D 1194 UNP P0DTC2 ASN 1194 ENGINEERED MUTATION SEQADV 6X45 NH2 D 1204 UNP P0DTC2 AMIDATION SEQADV 6X45 ACE C 911 UNP P0DTC2 ACETYLATION SEQADV 6X45 NH2 C 967 UNP P0DTC2 AMIDATION SEQADV 6X45 ACE F 1167 UNP P0DTC2 ACETYLATION SEQADV 6X45 GLN F 1171 UNP P0DTC2 GLY 1171 ENGINEERED MUTATION SEQADV 6X45 GLU F 1180 UNP P0DTC2 GLN 1180 ENGINEERED MUTATION SEQADV 6X45 TYR F 1181 UNP P0DTC2 LYS 1181 ENGINEERED MUTATION SEQADV 6X45 LYS F 1184 UNP P0DTC2 ASP 1184 ENGINEERED MUTATION SEQADV 6X45 LYS F 1185 UNP P0DTC2 ARG 1185 ENGINEERED MUTATION SEQADV 6X45 GLU F 1187 UNP P0DTC2 ASN 1187 ENGINEERED MUTATION SEQADV 6X45 LYS F 1192 UNP P0DTC2 ASN 1192 ENGINEERED MUTATION SEQADV 6X45 GLU F 1194 UNP P0DTC2 ASN 1194 ENGINEERED MUTATION SEQADV 6X45 NH2 F 1204 UNP P0DTC2 AMIDATION SEQADV 6X45 ACE B 911 UNP P0DTC2 ACETYLATION SEQADV 6X45 NH2 B 967 UNP P0DTC2 AMIDATION SEQADV 6X45 ACE A 911 UNP P0DTC2 ACETYLATION SEQADV 6X45 NH2 A 967 UNP P0DTC2 AMIDATION SEQRES 1 E 38 ACE ASP ILE SER GLN ILE ASN ALA SER VAL VAL ASN ILE SEQRES 2 E 38 GLU TYR GLU ILE LYS LYS LEU GLU GLU VAL ALA LYS LYS SEQRES 3 E 38 LEU GLU GLU SER LEU ILE ASP LEU GLN GLU LEU NH2 SEQRES 1 D 38 ACE ASP ILE SER GLN ILE ASN ALA SER VAL VAL ASN ILE SEQRES 2 D 38 GLU TYR GLU ILE LYS LYS LEU GLU GLU VAL ALA LYS LYS SEQRES 3 D 38 LEU GLU GLU SER LEU ILE ASP LEU GLN GLU LEU NH2 SEQRES 1 C 57 ACE THR GLN ASN VAL LEU TYR GLU ASN GLN LYS LEU ILE SEQRES 2 C 57 ALA ASN GLN PHE ASN SER ALA ILE GLY LYS ILE GLN ASP SEQRES 3 C 57 SER LEU SER SER THR ALA SER ALA LEU GLY LYS LEU GLN SEQRES 4 C 57 ASP VAL VAL ASN GLN ASN ALA GLN ALA LEU ASN THR LEU SEQRES 5 C 57 VAL LYS GLN LEU NH2 SEQRES 1 F 38 ACE ASP ILE SER GLN ILE ASN ALA SER VAL VAL ASN ILE SEQRES 2 F 38 GLU TYR GLU ILE LYS LYS LEU GLU GLU VAL ALA LYS LYS SEQRES 3 F 38 LEU GLU GLU SER LEU ILE ASP LEU GLN GLU LEU NH2 SEQRES 1 B 57 ACE THR GLN ASN VAL LEU TYR GLU ASN GLN LYS LEU ILE SEQRES 2 B 57 ALA ASN GLN PHE ASN SER ALA ILE GLY LYS ILE GLN ASP SEQRES 3 B 57 SER LEU SER SER THR ALA SER ALA LEU GLY LYS LEU GLN SEQRES 4 B 57 ASP VAL VAL ASN GLN ASN ALA GLN ALA LEU ASN THR LEU SEQRES 5 B 57 VAL LYS GLN LEU NH2 SEQRES 1 A 57 ACE THR GLN ASN VAL LEU TYR GLU ASN GLN LYS LEU ILE SEQRES 2 A 57 ALA ASN GLN PHE ASN SER ALA ILE GLY LYS ILE GLN ASP SEQRES 3 A 57 SER LEU SER SER THR ALA SER ALA LEU GLY LYS LEU GLN SEQRES 4 A 57 ASP VAL VAL ASN GLN ASN ALA GLN ALA LEU ASN THR LEU SEQRES 5 A 57 VAL LYS GLN LEU NH2 HET NH2 D1204 3 HETNAM NH2 AMINO GROUP FORMUL 2 NH2 H2 N FORMUL 7 HOH *8(H2 O) HELIX 1 AA1 ILE E 1179 LEU E 1193 1 15 HELIX 2 AA2 GLU E 1194 LEU E 1197 5 4 HELIX 3 AA3 ASP D 1168 ILE D 1172 5 5 HELIX 4 AA4 ILE D 1179 LEU D 1193 1 15 HELIX 5 AA5 GLU D 1194 LEU D 1197 5 4 HELIX 6 AA6 VAL C 915 GLN C 965 1 51 HELIX 7 AA7 ASP F 1168 ILE F 1172 5 5 HELIX 8 AA8 ILE F 1179 LEU F 1193 1 15 HELIX 9 AA9 GLU F 1194 LEU F 1197 5 4 HELIX 10 AB1 VAL B 915 ASN B 919 1 5 HELIX 11 AB2 ASN B 919 GLN B 965 1 47 HELIX 12 AB3 TYR A 917 GLN A 965 1 49 LINK C LEU D1203 N NH2 D1204 1555 1555 1.33 CRYST1 53.543 54.458 80.119 90.00 90.00 90.00 P 21 21 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018677 0.000000 0.000000 0.00000 SCALE2 0.000000 0.018363 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012481 0.00000